hsa-miR-9-3p

ncRNA information

ncRNA

hsa-miR-9-3p

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factor

Not available

Downstream target

Not available

Differential expression in
recurrence vs. nonrecurrence

Not available

Cancer information

Cancer name

Nasopharyngeal Carcinoma

Alias

Cancer site

Nasopharynx

Recurrence type

Recurrence

Clinical information

Overall survival rate of patients with
high ncRNA expression

Up

ncRNA differential expression in
cancer patients vs. health people

Not available

Number of patients

137

Male patients

102

Female patients

35

Age range and number

Not available


Recurrence patients

Not available

Recurrence patients male:female

Not available

Recurrence patients age range

Not available

Recurrence mean age

Not available

Sites of recurrence

Not available


Patients without recurrence

Not available

Patients without recurrence male:female

Patients without recurrence age range

Not available

Patients without recurrence mean age

Not available

Research information

PMID

Description

After treatment compared with pretreatment, and the four plasma miRNAs were downregulated again at recurrence or metastasis.

Tissue resource

blood samples from NPC and healthy donors

blood samples from NPC and healthy donors

blood samples from NPC and healthy donors

blood samples from NPC and healthy donors

Experiment

qRT-PCR


Institute

the Nanfang Hospital

Country

China

Continent

Asia